Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe
Jiong Tao1, Hilde Van Esch, M Hagedorn-Greiwe
1Max-Planck-Institute for Molecular Genetics, Berlin, Germany.
Abstract:
Recently, we showed that truncation of the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene caused mental retardation and severe neurological symptoms in two female patients. Here, we report that de novo missense mutations in CDKL5 are associated with a severe phenotype of early-onset infantile spasms and clinical features that overlap those of other neurodevelopmental disorders, such as Rett syndrome and Angelman syndrome. The mutations are located within the protein kinase domain and affect highly conserved amino acids; this strongly suggests that impaired CDKL5 catalytic activity plays an important role in the pathogenesis of this neurodevelopmental disorder. In view of the overlapping phenotypic spectrum of CDKL5 and MECP2 mutations, it is tempting to speculate that these two genes play a role in a common pathogenic process.
Insights
Mutations in the CDKL5 gene cause early-onset infantile spasms and overlap with Rett and Angelman syndromes. Impaired CDKL5 kinase activity is implicated in this severe neurodevelopmental disorder.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- The X-linked cyclin-dependent kinase-like 5 (CDKL5) gene is crucial for neurodevelopment.
- Previous studies linked CDKL5 gene truncation to mental retardation and neurological deficits.
Observation:
- This study identifies de novo missense mutations in the CDKL5 gene.
- These mutations are associated with a severe phenotype including early-onset infantile spasms.
- Clinical features overlap with Rett syndrome and Angelman syndrome.
Findings:
- Mutations are located in the protein kinase domain, affecting conserved amino acids.
- Impaired CDKL5 catalytic activity is strongly suggested as a key factor in pathogenesis.
- The findings point to CDKL5 as a significant gene in early-onset neurodevelopmental disorders.
Implications:
- CDKL5 mutations contribute to a spectrum of severe neurodevelopmental disorders.
- The overlapping phenotype with MECP2 mutations suggests a common pathogenic pathway.
- Further research into CDKL5 function may reveal therapeutic targets for related disorders.
Related Concept Videos
Sex-linked Disorders
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules
Anaphase Promoting Complex
Pleiotropy


